LENSAR, Inc. is a medical device manufacturer that develops and sells robotic femtosecond laser systems for cataract surgery, primarily its ALLY System, which combines proprietary imaging, automated treatment planning, and precision robotic capabilities to improve surgical outcomes and correct corneal astigmatism. The company targets cataract surgeons, ambulatory surgery centers, and hospitals globally, with a direct sales force in the U.S. and international distributors in Europe and Asia. LENSAR generates revenue through system purchases and leases from surgical practices and facilities, which then charge patients separately for laser-assisted procedures—a model that works because standard cataract surgery is insurance-covered but premium laser-assisted procedures with astigmatism correction require out-of-pocket patient payment.